Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9404499 | Surgery | 2005 | 9 Pages |
Abstract
The 5/3 fiber-modified, COX-2 promoter-driven CRAds may prove to be a new agent for the treatment of gallbladder carcinoma.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Yaman MD, Julia MD, PhD, Pedro J. MD, David T. MD, PhD, Selwyn M. MD, Masato MD, PhD,